Paperpal Prime Logo

Current Atherosclerosis Reports : Impact Factor & More

eISSN: 1534-6242pISSN: 1523-3804

Key Metrics

CiteScore
7.3
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SJR
Q1Cardiology and Cardiovascular Medicine
SNIP
1.28
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Current Atherosclerosis Reports

Current Atherosclerosis Reports Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher CURRENT MEDICINE GROUP
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1998
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Current Atherosclerosis Reports ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Current Atherosclerosis Reports

Sphingolipids and Atherosclerosis.
  • 6 Aug 2026
  • Current atherosclerosis reports
Exercise Training and Heart Rate Variability: A Guided Optimization of Cardiorespiratory Fitness in Cardiometabolic Disease.
  • 6 Aug 2026
  • Current atherosclerosis reports
Combination cardiometabolic therapy in type 2 diabetes: optimizing SGLT2 inhibitor and GLP‑1 receptor agonist use.
  • 18 Jul 2026
  • Current atherosclerosis reports
Social Isolation, Loneliness and Subclinical Atherosclerosis.
  • 16 Jul 2026
  • Current atherosclerosis reports
The Role of Furin in Hallmarks of Aneurysms: A Focus On Its Substrates.
  • 14 Jul 2026
  • Current atherosclerosis reports
The Angiopoietin-like Protein (ANGPTL) Axis in Dyslipidemia: Mechanisms, Cardiovascular Risk, and Emerging Therapies.
  • 11 Jul 2026
  • Current atherosclerosis reports
Sphingolipids and Atherosclerosis.
  • 6 Aug 2026
  • Current atherosclerosis reports
Exercise Training and Heart Rate Variability: A Guided Optimization of Cardiorespiratory Fitness in Cardiometabolic Disease.
  • 6 Aug 2026
  • Current atherosclerosis reports
Combination cardiometabolic therapy in type 2 diabetes: optimizing SGLT2 inhibitor and GLP‑1 receptor agonist use.
  • 18 Jul 2026
  • Current atherosclerosis reports
Social Isolation, Loneliness and Subclinical Atherosclerosis.
  • 16 Jul 2026
  • Current atherosclerosis reports
The Role of Furin in Hallmarks of Aneurysms: A Focus On Its Substrates.
  • 14 Jul 2026
  • Current atherosclerosis reports
The Angiopoietin-like Protein (ANGPTL) Axis in Dyslipidemia: Mechanisms, Cardiovascular Risk, and Emerging Therapies.
  • 11 Jul 2026
  • Current atherosclerosis reports

FAQs on Current Atherosclerosis Reports